Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Return on Sales (2016 - 2025)

Historic Return on Sales for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to 0.16%.

  • Healthequity's Return on Sales rose 1400.0% to 0.16% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.15%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.08% for FY2025, which is 200.0% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Return on Sales is 0.16%, which was up 1400.0% from 0.18% recorded in Q3 2025.
  • In the past 5 years, Healthequity's Return on Sales ranged from a high of 0.18% in Q3 2025 and a low of 0.16% during Q1 2022
  • Over the past 5 years, Healthequity's median Return on Sales value was 0.02% (recorded in 2021), while the average stood at 0.04%.
  • As far as peak fluctuations go, Healthequity's Return on Sales plummeted by -1900bps in 2022, and later skyrocketed by 1600bps in 2023.
  • Over the past 5 years, Healthequity's Return on Sales (Quarter) stood at 0.03% in 2021, then soared by 73bps to 0.01% in 2022, then soared by 875bps to 0.06% in 2023, then crashed by -68bps to 0.02% in 2024, then surged by 745bps to 0.16% in 2025.
  • Its Return on Sales was 0.16% in Q4 2025, compared to 0.18% in Q3 2025 and 0.16% in Q2 2025.